MARC details
000 -LEADER |
fixed length control field |
04218naaaa2200877uu 4500 |
001 - CONTROL NUMBER |
control field |
https://directory.doabooks.org/handle/20.500.12854/42637 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20220714190620.0 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
books978-3-03921-464-8 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783039214648 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783039214631 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.3390/books978-3-03921-464-8 |
Terms of availability |
doi |
041 0# - LANGUAGE CODE |
Language code of text/sound track or separate title |
English |
042 ## - AUTHENTICATION CODE |
Authentication code |
dc |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Lee, Nikki |
Relator code |
auth |
9 (RLIN) |
1611759 |
245 10 - TITLE STATEMENT |
Title |
Cancer Biomarkers and Targets in Digestive Organs |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Name of publisher, distributor, etc |
MDPI - Multidisciplinary Digital Publishing Institute |
Date of publication, distribution, etc |
2019 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 electronic resource (146 p.) |
506 0# - RESTRICTIONS ON ACCESS NOTE |
Terms governing access |
Open Access |
Source of term |
star |
Standardized terminology for access restriction |
Unrestricted online access |
520 ## - SUMMARY, ETC. |
Summary, etc |
Identification and development of cancer biomarkers and targets have greatly accelerated progress towards precision medicine in oncology. Studies of tumor biology have not only provided insights into the mechanisms underlying carcinogenesis, but also led to discovery of molecules that have been developed into cancer biomarkers and targets. Multi-platforms for molecular characterization of tumors using next-generation genomic sequencing, immunohistochemistry, in situ hybridization, and blood-based biopsies have greatly expanded the portfolio of potential biomarkers and targets. These cancer biomarkers have been developed for diagnosis, early detection, prognosis, and prediction of treatment response. The molecular targets have been exploited for anti-cancer therapy and delivery of therapeutic agents. This Special Issue of Biomedicines focuses on recent advances in the discovery, characterization, translation, and clinical application of cancer biomarkers and targets in malignant diseases of the digestive system. The goal is to stimulate basic and translational research and clinical collaboration in this exciting field with the hope of developing strategies for prevention and early detection/diagnosis of cancer in digestive organs, and improving therapeutic and psychosocial outcomes in patients with these malignant diseases. |
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE |
Terms governing use and reproduction |
Creative Commons |
-- |
https://creativecommons.org/licenses/by-nc-nd/4.0/ |
-- |
cc |
-- |
https://creativecommons.org/licenses/by-nc-nd/4.0/ |
546 ## - LANGUAGE NOTE |
Language note |
English |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
n/a |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
liver graft injury |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
HFE |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
neurokinin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
chemotherapy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
intestinal tumors |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
therapeutic targets |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
biliary tract carcinoma |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
hepatocellular carcinoma |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
clinical trial |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cell adhesion molecules |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
colorectal cancer |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
biomarkers |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
phenotypic mosaics |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
gastrointestinal oncology |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Asian Cancer Research Group (ACRG) |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
biomarker |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
psychosocial support |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
precision therapy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
pancreatic carcinoma |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
precision medicine |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Liver transplantation |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
predictive biomarkers |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
CD274 |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cholecystokinin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
The Cancer Genome Atlas (TCGA) |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
gastrin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
pembrolizumab |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immunotherapy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
gastrin-releasing peptide |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
stereotactic body radiation therapy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immunohistochemistry |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
gastric carcinoma |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
liver transplant |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
CAM invasion assay |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
intragraft gene expression profiles |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
molecular profiling |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
targeted therapy |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
neurotensin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
intestinal disorder |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
ramucirumab |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
next-generation sequencing |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
colorectal carcinoma |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
tumor progenitor |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
circulating tumor cells |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
gastrointestinal malignancies |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
bombesin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
trastuzumab |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
somatostatin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
zebrafish |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
G protein-coupled receptors |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Yee, Nelson |
Relator code |
auth |
9 (RLIN) |
1611760 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Host name |
www.oapen.org |
Uniform Resource Identifier |
<a href="https://mdpi.com/books/pdfview/book/1534">https://mdpi.com/books/pdfview/book/1534</a> |
-- |
0 |
Public note |
DOAB: download the publication |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Host name |
www.oapen.org |
Uniform Resource Identifier |
<a href="https://directory.doabooks.org/handle/20.500.12854/42637">https://directory.doabooks.org/handle/20.500.12854/42637</a> |
-- |
0 |
Public note |
DOAB: description of the publication |